Spelling suggestions: "subject:"agatologia"" "subject:"ematologia""
21 |
Preclinical development of anti-cancer strategies against human HER-2Dall'Ora, Massimiliano <1983> 11 May 2015 (has links)
HER-2 is a 185 kDa transmembrane receptor tyrosine kinase that belongs to the EGFR family. HER-2 is overexpressed in nearly 25% of human breast cancers and women with this subtype of breast cancer have a worse prognosis and frequently develop metastases. The progressive high number of HER-2-positive breast cancer patients with metastatic spread in the brain (up to half of women) has been attributed to the reduction in mortality, the effectiveness of Trastuzumab in killing metastatic cells in other organs and to its incapability to cross the blood-brain barrier. Apart from full-length-HER-2, a splice variant of HER-2 lacking exon 16 (here referred to as D16) was identified in human HER-2-positive breast cancers.
Here, the contribution of HER-2 and D16 to mammary carcinogenesis was investigated in a model transgenic for both genes (F1 model). A dominant role of D16, especially in early stages of tumorigenesis, was suggested and the coexistence of heterogeneous levels of HER-2 and D16 in F1 tumors revealed the undeniable value of F1 strain as preclinical model of HER-2-positive breast cancer, closer resembling the human situation in respect to previous models.
The therapeutical efficacy of anti-HER-2 agents, targeting HER-2 receptor (Trastuzumab, Lapatinib, R-LM249) or signaling effectors (Dasatinib, UO126, NVP-BKM120), was investigated in models of local or advanced HER-2-positive breast cancer. In contrast with early studies, data herein collected suggested that the presence of D16 can predict a better response to Trastuzumab and other agents targeting HER-2 receptor or Src activity. Using a multiorgan HER-2-positive metastatic model, the efficacy of NVP-BKM120 (PI3K inhibitor) in blocking the growth of brain metastases and the oncolytic ability of R-LM249 (HER-2-retargeted HSV) to reach and destroy metastatic HER-2-positive cancer cells were shown.
Finally, exploiting the definition of “oncoantigen” given to HER-2, the immunopreventive activity of two vaccines on HER-2-positive mammary tumorigenesis was demonstrated.
|
22 |
The elderly health status and its correlation with ageing biomarkers: the European Project Mark-AgePini, Elisa <1971> January 1900 (has links)
According to the latest statistics projections formulated by Eurostat, the proportion of elderly EU-27’s population aged over 65 years old is predicted to increase from 17.5 % in 2011 to 29.5 % by 2060. This "population explosion" makes extremely important to identify the different genetic and molecular mechanisms which underpin the morbidity and mortality along with new strategies able to counteract or slow down its progress. In this scenario fits the European Project MARK-AGE whose aim was to identify a robust set of biomarkers of human ageing able to discriminate between chronological and biological ageing and to derive a model for healthy ageing through the analysis of three populations from different European countries, supposed to be characterized by different ageing rate: 1. Subjects representing the “Normal” or “Physiological” aging. 2. Subjects representing the “successful” or “decelerate” aging 3. Subjects representing the “accelerated” aging. The aim of this work was to recruit and characterize volunteers, to perform an accurate analysis of the health status of elderly recruited subjects (60-79 years) verifying any possible dissimilarity in their aging trajectories, to identify a set of robust ageing biomarkers and investigate possible correlations between ageing biomarkers and health status of recruited volunteers. The model proposed by MARK-AGE Project regarding different ageing trajectories has been confirmed and several ageing biomarkers have been identified.
|
23 |
Data management and data analysis in the large European projects GEHA (GEnetics of Healthy Aging) and NU-AGE (NUtrition and AGEing): a bioinformatic approachVianello, Dario <1987> 11 May 2015 (has links)
The aging process is characterized by the progressive fitness decline experienced at all the levels of physiological organization, from single molecules up to the whole organism. Studies confirmed inflammaging, a chronic low-level inflammation, as a deeply intertwined partner of the aging process, which may provide the “common soil” upon which age-related diseases develop and flourish. Thus, albeit inflammation per se represents a physiological process, it can rapidly become detrimental if it goes out of control causing an excess of local and systemic inflammatory response, a striking risk factor for the elderly population. Developing interventions to counteract the establishment of this state is thus a top priority. Diet, among other factors, represents a good candidate to regulate inflammation. Building on top of this consideration, the EU project NU-AGE is now trying to assess if a Mediterranean diet, fortified for the elderly population needs, may help in modulating inflammaging. To do so, NU-AGE enrolled a total of 1250 subjects, half of which followed a 1-year long diet, and characterized them by mean of the most advanced –omics and non –omics analyses. The aim of this thesis was the development of a solid data management pipeline able to efficiently cope with the results of these assays, which are now flowing inside a centralized database, ready to be used to test the most disparate scientific hypotheses. At the same time, the work hereby described encompasses the data analysis of the GEHA project, which was focused on identifying the genetic determinants of longevity, with a particular focus on developing and applying a method for detecting epistatic interactions in human mtDNA. Eventually, in an effort to propel the adoption of NGS technologies in everyday pipeline, we developed a NGS variant calling pipeline devoted to solve all the sequencing-related issues of the mtDNA.
|
24 |
Epigenetic signature in persons with Down SyndromeFontanesi, Elisa <1984> 11 May 2015 (has links)
Persons affected by Down Syndrome show a heterogeneous phenotype that includes developmental defects and cognitive and haematological disorders. Premature accelerated aging and the consequent development of age associated diseases like Alzheimer Disease (AD) seem to be the cause of higher mortality late in life of DS persons.
Down Syndrome is caused by the complete or partial trisomy of chromosome 21, but it is not clear if the molecular alterations of the disease are triggered by the specific functions of a limited number of genes on chromosome 21 or by the disruption of genetic homeostasis due the presence of a trisomic chromosome. As epigenomic studies can help to shed light on this issue, here we used the Infinium HumanMethilation450 BeadChip to analyse blood DNA methylation patterns of 29 persons affected by Down syndrome (DSP), using their healthy siblings (DSS) and mothers (DSM) as controls. In this way we obtained a family-based model that allowed us to monitor possible confounding effects on DNA methylation patterns deriving from genetic and environmental factors.
We showed that defects in DNA methylation map in genes involved in developmental, neurological and haematological pathways. These genes are enriched on chromosome 21 but localize also in the rest of the genome, suggesting that the trisomy of specific genes on chromosome 21 induces a cascade of events that engages many genes on other chromosomes and results in a global alteration of genomic function. We also analysed the methylation status of three target regions localized at the promoter (Ribo) and at the 5’ sequences of 18S and 28S regions of the rDNA, identifying differently methylated CpG sites.
In conclusion, we identified an epigenetic signature of Down Syndrome in blood cells that sustains a link between developmental defects and disease phenotype, including segmental premature aging.
|
25 |
Aging in human liver and skeletal muscle: studies on proteasomesMartucci, Morena <1983> 16 May 2014 (has links)
Aging is a complex phenomenon that affects organs and tissues at a different rate. With advancing age, the skeletal muscle undergoes a progressive loss of mass and strength, a process known as sarcopenia that leads to a decreased mobility and increased risk of falls and invalidity. On the other side, another organ such as the liver that is endowed with a peculiar regenerative capacity seems to be only marginally affected by aging. Accordingly, clinical data indicate that liver transplantation from aged subjects has, in specific conditions, function and duration comparable to those achievable with grafts of liver from young donors. The molecular mechanisms involved in these peculiar aging patterns are still largely unknown, but it is conceivable that protein degradation machineries might play an important role, as they are responsible for the maintenance of cellular homeostasis. Indeed, it has been suggested that alteration of proteostasis may contribute to the onset and progression of several age-related pathological conditions, including skeletal muscle wasting and sarcopenia, as well as to the aging phenotypes.
The ubiquitin-proteasome system (UPS) is one of the most important cellular pathways for intracellular degradation of short-lived as well as damaged proteins. To date, studies on the age-related modifications of proteasomes in liver and skeletal muscle were performed prevalently in rodents, with controversial results, while only preliminary observations have been obtained in human liver and skeletal muscle. In this scenario, we want to investigate and characterize in humans the age-related modifications of proteasomes of these two different organs.
|
26 |
Aureobasidium pullulans as biological control agent: modes of actionDi Francesco, Alessandra <1985> January 1900 (has links)
The postharvest phase has been considered an environment very suitable for successful application of biological control agents (BCAs). However, the tri-interaction between fungal pathogen, host (fruit) and antagonist is influenced by several parameters such as temperature, oxidative stresses, oxygen composition, water activity, etc. that could be determining for the success of biocontrol. Knowledge of the modes of action of BCAs is essential in order to enhance their viability and increase their potentialities in disease control.
The thesis focused on the possibility to explain the modes of action of a biological control agent (BCA): Aureobasidium pullulans, in particular the strains L1 and L8, control effective against fruit postharvest fungal pathogen.
In particular in this work were studied the different modes of action of BCA, such as:
i) the ability to produce volatile organic compounds (VOCs), identified by SPME- gas chromatography-mass spectrometry (GC-MS) and tested by in vitro and in vivo assays against Penicillium spp., Botrytis cinerea, Colletotrichum acutatum;
ii) the ability to produce lytic enzymes (exo and endo chitinase and β-1,3-glucanase) tested against Monilinia laxa, causal agent of brown rot of stone fruits. L1 and L8 lytic enzymes were also evaluated through their relative genes by molecular tools;
iii) the competition for space and nutrients, such as sugars (sucrose, glucose and fructose) and iron; the latter induced the production of siderophores, molecules with high affinity for iron chelation. A molecular investigation was carried out to better understand the gene regulation strictly correlated to the production of these chelating molucules.
The competition for space against M. laxa was verified by electron microscopy techniques;
iv) a depth bibliographical analysis on BCAs mechanisms of action and their possible combination with physical and chemical treatments was conducted.
|
27 |
Caratterizzazione bio-molecolar e ruolo di specie di Fusarium associate alla Fusariosi della spiga su frumento duro / Bio-molecular characterization and role of Fusarium species involved in Fusarium Head Blight of durum wheatAmato, Barbara <1984> 08 May 2015 (has links)
La Fusariosi della spiga (FDS) è una fitopatia diffusa a livello mondiale che colpisce le colture cerealicole, tra cui il frumento duro, ed è in grado di causare gravi danni di tipo qualitativo ed economico. Le specie fungine responsabili appartengono al genere Fusarium, tra cui F. graminearum, F. culmorum e più recentemente F. poae. La conseguenza più rilevante riguarda la contaminazione della granella da micotossine, molecole prodotte dai miceti, considerate dalla comunità scientifica ad alto rischio per la salute dell’uomo e animali.
L’eziologia è molto complessa, dal momento che su una stessa spiga di frumento possono coesistere più specie fungine che contribuiscono ad influenzare i quantitativi di micotossine prodotte.
Lo scopo della ricerca è incentrato sulla caratterizzazione di ceppi di F. poae, in termini di potenziale patogeno e aggressività. Tramite l’allestimento di un saggio di inoculazione in vitro “Petri-dish” è stato possibile attribuire un indice di aggressività a ciascun isolato fungino, basato su parametri quali AUHPC e AUDPC standard, insieme ad altre variabili come la riduzione della lunghezza del coleottile e del tasso di germinazione. Il saggio è stato esteso anche a F. culmorum, per valutare la riproducibilità del test su altre specie fungine. Il test in vitro offre diversi vantaggi, tra cui affidabilità e rapidità di esecuzione ed è quindi adatto allo screening di ceppi patogeni da utilizzare in successive sperimentazioni.
Gli stessi ceppi di F. poae, provenienti da una prova di inoculazione artificiale in serra su piante di frumento duro, sono stati caratterizzati dal punto di vista bio-molecolare.
Poichè lo studio della fusariosi della spiga richiede la determinazione quantitativa della biomassa dei patogeni nei tessuti della pianta-ospite, anche in assenza di sintomi, il protocollo di Real-Time PCR con chimica SYBR® Green I qui sviluppato, ha dimostrato essere un buon compromesso tra attendibilità, rapidità e costi complessivi della metodica. / Fusarium Head Blight (FHB) is one of the major diseases affecting worldwide cereral crops. It causes yield losses and decreasing grain quality, including the accumulation of mycotoxins. The causal agents, F. graminearum, F. culmorum and recently F. poae, belong to Fusarium genus. Contamination by mycotoxins is a great concern, as they are capable of harming the health of humans and farm animals.
The aetiology is very complex, as one or more species can occur on a spike at the same time and can contribute to the total amount of mycotoxins.
The aim of the research has been the characterization of F. poae strains regarding their pathogenicity and aggressiveness. It has been possible, by an in vitro “Petri-dish” test, to confer an aggressiveness index to each isolate, based on AUHPC and AUDPC standard parameters, together with the variables on germination rate reduction and coleoptile length reduction. The same test was also performed on F. culmorum strains, to assess its reproducibility on other Fusarium species; the benefits arisen from the test, which are reliability and rapidity in execution, make it suitable for screening analyses of pathogen strains that can be used for other purposes.
The same F. poae strains, from a greenhouse artificial inoculation experiment on durum wheat plants, were also biomolecularly characterized.
Estimation of fungal biomass, even in asymptomatic spikes, is fundamental to assess the pathogenicity of strains and it was possible by the Real-time PCR molecular technique with SYBR® Green I chemistry developed in this work, which showed to be sensitive, fast and specific for quantifying F. poae biomass.
|
28 |
Cancer and aging: a multidisciplinary medicinal chemistry approach on relevant biological targets such as proteasome, sirtuins and interleukin 6Parenti, Marco Daniele <1975> 11 May 2015 (has links)
It is well known that ageing and cancer have common origins due to internal and environmental stress and share some common hallmarks such as genomic instability, epigenetic alteration, aberrant telomeres, inflammation and immune injury. Moreover, ageing is involved in a number of events responsible for carcinogenesis and cancer development at the molecular, cellular, and tissue levels.
Ageing could represent a “blockbuster” market because the target patient group includes potentially every person; at the same time, oncology has become the largest therapeutic area in the pharmaceutical industry in terms of the number of projects, clinical trials and research and development (R&D) spending, but cancer remains one of the leading causes of mortality worldwide.
The overall aim of the work presented in this thesis was the rational design of new compounds able to modulate activity of relevant targets involved in cancer and aging-related pathologies, namely proteasome and immunoproteasome, sirtuins and interleukin 6. These three targets play different roles in human cells, but the modulation of its activity using small molecules could have beneficial effects on one or more aging-related diseases and cancer.
We identified new moderately active and selective non-peptidic compounds able to inhibit the activity of both standard and immunoproteasome, as well as novel and selective scaffolds that would bind and inhibit SIRT6 selectively and can be used to sensitize tumor cells to commonly used anticancer agents such gemcitabine and olaparib. Moreover, our virtual screening approach led us also to the discovery of new putative modulators of SIRT3 with interesting in-vitro and cellular activity.
Although the selectivity and potency of the identified chemical scaffolds are susceptible to be further improved, these compounds can be considered as highly promising leads for the development of future therapeutics.
|
29 |
Patogenesi molecolare delle osteomieliti associate all'impianto / Molecular pathogenesis of implant-associated osteomyelitisTestoni, Francesca <1985> 11 May 2015 (has links)
L’osteomielite associata all’impianto è un processo infettivo a carico del tessuto osseo spesso accompagnato dalla distruzione dell’osso stesso. La patogenesi delle osteomieliti associate all’impianto si basa su due concetti fondamentali: l’internalizzazione del patogeno all’interno degli osteoblasti e la capacità dei batteri di formare il biofilm. Entrambi i meccanismi consentono infatti di prevenire l’eliminazione del batterio da parte delle difese immunitarie dell’ospite e di ostacolare l’azione della maggior parte degli antibiotici (che non penetrano e non agiscono pertanto su microrganismi intracellulari), così sostenendo ed alimentando l’infezione.
Il saggio di invasione messo a punto su micropiastra ha consentito di investigare in modo approfondito e dettagliato il ruolo ed il peso dell’internalizzazione nella patogenesi delle infezioni ortopediche peri-protesiche causate da S. aureus, S. epidermidis, S. lugdunensis ed E. faecalis.
Lo studio ha evidenziato che l’invasione delle cellule MG-63 non rappresenta un meccanismo patogenetico delle infezioni ortopediche associate all’impianto causate da S. epidermidis, S. lugdunensis ed E. faecalis; al contrario, in S. aureus la spiccata capacità invasiva rappresenta un’abile strategia patogenetica che consente al patogeno di sfuggire alla terapia sistemica e alla risposta immunitaria dell’ospite. È stato studiato inoltre il ruolo dell’immunità innata nella difesa contro il biofilm batterico. In seguito all’incubazione del biofilm opsonizzato di S. epidermidis con i PMN è stato possibile osservare la formazione delle NETs. Le NETs rappresentano ottime armi nella difesa contro il biofilm batterico, infatti le trappole sono in grado di limitare la diffusione batterica e quindi di confinare l’infezione. La comprensione del ruolo dell’internalizzazione nella patogenesi delle osteomieliti associate all’impianto e lo studio della risposta immunitaria innata a questo tipo di infezioni, spesso caratterizzate dalla presenza di biofilm, sono presupposti per identificare e affinare le migliori strategie terapeutiche necessarie ad eradicare l'infezione. / Impant-associated osteomyelitis is an infective process against bone tissue and it often leads to the destruction of the bone itself. The pathogenesis of impant-associated osteomyelitis is based on two fundamental concepts: internalization of pathogens into osteoblasts and bacterial ability to form biofilm. Both mechanisms allow to prevent bacterial elimination by host immune system and to block the action of majority antibiotics (that do not penetrate and have effect on intracellular bacteria) sustaining and feeding in this way the infection. The microplate-based assay allow to investigate the role of internalization mechanism in the pathogenesis of orthopaedic implant-infections caused by S. aureus, S. epidermidis, S. lugdunensis and E. faecalis. The study demonstrated the incompetence of S. epidermidis, S. lugdunensis and E. faecalis clinical isolates to invade MG-63 cells, on the opposite S. aureus invasion ability represents an optimal pathogenetic strategy for the pathogen to elude systemic therapy and host immune response. In addition here we investigate the role of innate immune response against bacterial biofilm. The interaction between S. epidermidis opsonized biofilm and PMN allowed to visualize the NETs. Neutrophil extracellular traps represent optimal weapon against bacterial biofilm because they wrap bacteria and so confine the infection. The understanding of internalization role in the pathogenesis of implant-associated osteomyelitis and the study of innate immune response against this kind of infection, often characterized by biofilm presence, are the basis to identify the best therapeutic strategy in order to eradicate the infection.
|
30 |
High sensitivity analysis of BRAF mutations in neoplastic and non-neoplastic thyroid lesionsCesari, Valentina <1985> 07 April 2014 (has links)
The clonal distribution of BRAFV600E in papillary thyroid carcinoma (PTC) has been recently debated. No information is currently available about precursor lesions of PTCs.
My first aim was to establish whether the BRAFV600E mutation occurs as a subclonal event in PTCs. My second aim was to screen BRAF mutations in histologically benign tissue of cases with BRAFV600E or BRAFwt PTCs in order to identify putative precursor lesions of PTCs. Highly sensitive semi-quantitative methods were used: Allele Specific LNA quantitative PCR (ASLNAqPCR) and 454 Next-Generation Sequencing (NGS).
For the first aim 155 consecutive formalin-fixed and paraffin-embedded (FFPE) specimens of PTCs were analyzed. The percentage of mutated cells obtained was normalized to the estimated number of neoplastic cells. Three groups of tumors were identified: a first had a percentage of BRAF mutated neoplastic cells > 80%; a second group showed a number of BRAF mutated neoplastic cells < 30%; a third group had a distribution of BRAFV600E between 30-80%. The large presence of BRAFV600E mutated neoplastic cell sub-populations suggests that BRAFV600E may be acquired early during tumorigenesis: therefore, BRAFV600E can be heterogeneously distributed in PTC.
For the second aim, two groups were studied: one consisted of 20 cases with BRAFV600E mutated PTC, the other of 9 BRAFwt PTCs. Seventy-five and 23 histologically benign FFPE thyroid specimens were analyzed from the BRAFV600E mutated and BRAFwt PTC groups, respectively.
The screening of BRAF mutations identified BRAFV600E in “atypical” cell foci from both groups of patients. “Unusual” BRAF substitutions were observed in histologically benign thyroid associated with BRAFV600E PTCs. These mutations were very uncommon in the group with BRAFwt PTCs and in BRAFV600E PTCs. Therefore, lesions carrying BRAF mutations may represent “abortive” attempts at cancer development: only BRAFV600E boosts neoplastic transformation to PTC.
BRAFV600E mutated “atypical foci” may represent precursor lesions of BRAFV600E mutated PTCs.
|
Page generated in 0.0553 seconds